Breschi, G.L., Demma, F., Morelli, P. and De Francesco, M. 2021. Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy. AboutOpen. 8, 1 (Sep. 2021), 81–87. DOI:https://doi.org/10.33393/ao.2021.2263.